KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology
KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology
KeyBanc以增持方式启动标准BioTools，目标股价为4美元，认为生命科学技术是 “具有吸引力的投资方式”
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册